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Objective: To determine the relationship between insulin resistance and 
related variables (serum testosterone, interleukin (IL-6) and leptin level) in 
obese and non-obese healthy subjects. Methods: Community-based cross-
sectional, analytic study was undertaken in 60 subjects for each obese 
group (BMI ≥ 30.0 kg/m2) and non-obese group (BMI 18.5 to 24.9 kg/
m2) (age;18-45 years) residing in Magway Township from December 
2016  to December 2017. Serum insulin, testosterone, IL-6 and leptin 
levels were measured by enzyme linked immunoassay, and serum fasting 
glucose was measured by glucose oxidase method. Insulin sensitivity was 
calculated by HOMA formula (Homeostatic Model Assessment). Results: 
HOMA-IR, serum leptin and IL-6 level were significantly higher in obese 
group while serum testosterone level was significantly lower in obese 
group. There was a significantly correlation between HOMA-IR with 
leptin (r=0.306, p=0.001), IL-6 (r=0.237, p=0.009) and testosterone (r=-
0.209, p=0.02). Moreover, serum leptin was significantly and positively 
correlated with IL-6 (r=0.391, p<0.001) while serum testosterone was 
significantly and negatively correlated with leptin (r=-0.408, p<0.001), and 
IL-6 (r=-0.34, p<0.001). Conclusions:  Obese men are more likely to have 
low testosterone, high inflammatory markers leptin and Il-6, which were 








The prevalence of obesity is rapidly worldwide. At 
least 2.8 million people die each year as a result of being 
overweight or obese [1]. Obesity is considered as chronic 
inflammatory disease. Leptin and IL-6 are known as low 
grade inflammatory markers which released from adipose 
tissue [2]. Most of studies have shown the significant asso-
ciation between these inflammatory cytokines (Leptin and 
IL-6) and obesity [3,4].
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Liu et al [5] reported that 41% of obese patients without 
diabetes have insulin resistance. It has been reported that 
serum IL-6 level was significantly and positively associat-
ed with insulin resistance [6,7]  but few studies have found 
that IL-6 did not alter the effects of insulin on glucose 
homoeostasis [8]. Moreover, Senn et al [9] demonstrated 
that IL-6 induces cellular insulin resistance in hepatocyte. 
Considerable evidence from vitro study on rat adipocyte 
had shown that leptin impairs several metabolic actions 
of insulin [10]. A few studies indicated that serum leptin 
level was significantly and positively associated with in-
sulin resistance in women with metabolic syndrome [11], 
post-menopausal women [12], non-obese adolescents (boys 
and girls) [13] and obese women [14]. However there is pau-
city of literature on the effect of leptin in obese male indi-
viduals on insulin resistance.
Significance of low testosterone levels was seen in 
obese men [15-17]. Xia et al [18] have reported recently that 
serum testosterone level was significantly and negatively 
associated with insulin resistance in elderly male type 
2 diabetes mellitus (T2DM) patients with osteoporosis, 
whereas it has not been reported in inflammatory state 
of obesity. Moreover, there are convincing evidence 
demonstrated the important link between leptin, IL-6 and 
testosterone in vitro studies [19-21]. Thus serum leptin, IL-6 
and testosterone level attract considerable attention in 
development of insulin resistance in inflammatory state 
of obesity. Thus the present study aims to investigate the 
relationship between serum testosterone, leptin and IL-6 
levels and the relationship between each of these variables 
and insulin resistance in healthy adult male subjects.
2. Methodology
This cross-sectional analytical study was undertaken in 
apparently healthy non-obese and generally obese male 
adult subjects living in Magway Township, Myanmar 
from December 2016 to December 2017. Five quarters 
among total fifteen quarters in Magway Township were 
be selected by simple random sampling method. All the 
male subjects aged between 18-45 years residing in se-
lected five quarters were selected. After that, they were 
thoroughly explained about the research. The participation 
in present study was absolutely voluntary and written in-
formed consent was obtained. 
All participants were undertaken by history taking and 
physical examination. Subjects who are fasting blood 
sugar > 7 mmol/L, subjects who are history of diabetes, 
cardiovascular diseases, bone diseases, endocrine diseases 
such as hyperthyroidism, hypo or hyperparathyroidism 
and Cushing syndrome and acute infection, subjects who 
are blood pressure more than 140/90 mmHg, subjects who 
are taking anti-oxidants e.g. vitamin C and anti-inflam-
matory drugs e.g. steroids, chronic smoker and chronic 
alcoholic were excluded from the study. Chronic alcoholic 
are those who drink distilled spirit (especially rum, whis-
ky with 40 percent alcohol), an average of 140 ml/day 
for more than five years. Chronic smokers are those who 
had 25 or more pack-year of smoking history of any to-
bacco product such as cigarettes, cigars or rolled tobacco. 
The weight measurement was done by using a calibrated 
bathroom scale. Standing height was measured by using 
measuring tape. Body mass index was calculated. Waist 
circumference was measured by using a measuring tape. 
Then all the eligible subjects from each quarter were 
categorized into two groups; control group and obese 
group. Those with BMI 18.5-24.9 kg/m2 were selected in 
the non-obese group and those with BMI ≥ 30.0 kg/m2 
were selected in the obese group. There were a total of 10 
groups for five quarters. Twelve subjects from each group 
were recruited to the study by simple random sampling 
method. This was resulted in 60 subjects for each obese 
group and non-obese group. Age of the subjects was ad-
justed for each group. 
All subjects were instructed to arrive at quarter’s office 
at 8:00 am after fasting for 10 hours (from 10:00 pm to 
8:00 am). On arrival, fasting blood sample (10 ml) tak-
en by venipuncture was collected in two separate blood 
collecting tubes: one ml of blood was collected in tube 
containing10 mg of sodium fluoride for determination of 
blood sugar and 9 ml of blood in another tube for serum 
separation. Then all blood samples were transported to 
Common Research Laboratory, University of Medicine, 
Magway with effective cold chain system. On arrival, 
serum was separated and collected in 4 separate sample 
tubes and stored at  (-20°C) until the blood sample anal-
ysis: one for determination of serum IL-6, one for deter-
mination of serum leptin, one for determination of serum 
insulin and one for determination of serum testosterone. 
Blood glucose level was determined on the same day of 
blood collection. 
Data entry and analysis were done by SPSS software 
(version 22, SPSS Inc., Chicago, IL, USA). Independent 
“t” test was used to compare the normally distributed data 
and Mann-Whitney Test was used to compare the skewed 
data between non-obese and obese groups Correlation 
studies were done by Spearman’s correlation. Differences 
were considered significant when p< 0.05.
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3. Results 
Table 1 indicated that comparison of biochemical pa-
rameters between non-obese and obese groups. There 
were significantly higher blood glucose level, serum insu-
lin level, HOMA-IR, serum leptin level, serum IL 6 level 
and lower testosterone level in obese group compared 
with non-obese group. 
Correlation of HOMA-IR and serum leptin, IL-6, 
testosterone levels in study population was illustrated in 
figure 1. HOMA-IR was significantly and weak positively 
correlated with serum leptin and IL-6 levels (Figure 1A, 
B). There was a significant weak negative correlation be-
tween HOMA-IR and testosterone level (Figure 1C).
Figure 1A. Correlation between HOMA-IR and serum 
leptin level in study subjects
Notes:
r = spearman Correlation coefficient
n = total numbers of subjects
Statistical significant difference was set as p<0.05
Figure 1B. Correlation between HOMA-IR and serum 
IL-6 level in study subjects
Notes:
r = spearman Correlation coefficient
n = total numbers of subjects
Statistical significant difference was set as p<0.05
Figure 1C. Correlation between HOMA-IR and serum 
testosterone level in study subjects
Notes:
r = spearman Correlation coefficient
n = total numbers of subjects
Statistical significant difference was set as p<0.05







Mean ± SD or Median(IQR)
Blood glucose level    (mmol/L) 4.74±0.34 5.03±0.43 <0.001
Insulin (μIU/L) 10.31(8.03) 15.32(9.74) <0.001*
HOMA-IR 2.18(1.55) 3.58(2.37) <0.001*
Leptin (pg/ml) 3(2.48) 6(5.6) <0.001*
IL-6 (pg/ml) 10(8) 38(37.5) <0.001*
Testosterone (pg/ml) 5.55±2.43 4.07±1.34 <0.001
Note:
Independent t test, *Mann-Whitney test
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As shown in figure 2, there was significant weak nega-
tive correlation between IL-6 and testosterone level (Fig-
ure 2A) and between leptin and testosterone levels (Figure 
2B). Figure 2C showed that leptin was significantly and 
weak positively correlated with IL-6 level.
Figure 2A. Correlation between serum testosterone and 
serum IL-6 level in study subjects
Notes:
r = spearman Correlation coefficient
n = total numbers of subjects
Statistical significant difference was set as p<0.05
Figure 2B. Correlation between serum testosterone and 
serum leptin level in study subjects
Notes:
r = spearman Correlation coefficient
n = total numbers of subjects
Statistical significant difference was set as p<0.05
Figure 2C. Correlation between serum leptin and serum 
IL-6 level in study subjects
Notes:
r = spearman Correlation coefficient
n = total numbers of subjects
Statistical significant difference was set as p<0.05
4. Discussion
Obesity-associated insulin resistance is a major risk 
factor for T2DM and cardiovascular disease. Thus, 
a better understanding of the etiology of insulin re-
sistance will be required to combat the epidemics of 
T2DM and cardiovascular disease. Many studies had 
shown that there is a significant strong epidemiological 
association between obesity and the development of in-
sulin resistance [22-24] and even obese patients without di-
abetes have insulin resistance [5]. In present study, median 
(IQR) HOMA-IR of obese group was significantly higher 
than that of non-obese group (3.58(2.37) vs 2.18(1.55), p 
<0.001). Moreover, 75% of obese subjects were insulin 
resistance (HOMA-IR > 2.6) in present study. These find-
ings agree with the reports of previous studies [5,23,24]. 
Previous studies revealed that pro-inflammatory cyto-
kines and hormones released by adipose tissue and other 
factors have been proposed for the mechanisms by which 
obesity induced development of insulin resistance [2,6,10]. 
Ouchi et al [2] had reported that proinflammatory cytokines 
are over expressed in obesity. In our study, median (IQR) 
serum IL-6 level of obese group was significantly higher 
than that of non-obese group (38(37.5) vs 10(8) pg/ml, 
p <0.001). Possible mechanism of increased IL-6 level 
might be due to hyperplasia and hypertrophy of adipo-
cytes in obese individual. Due to progressive enlargement 
of adipocyte, blood supply to adipocytes may be reduced 
and adipocytes are hypoxic which in turn lead to necrosis 
and macrophage infiltration into adipose tissue that cause 
overproduction of pro-inflammatory mediators [25,26]. The 
studies of Kern et al [6] and Senn et al [9] had been discov-
ered that IL-6 contributes to insulin resistance in both hu-
mans and animals. IL-6 cause inhibition of action of insu-
lin in primary hepatocytes, insulin-induced Akt activation 
and glycogen synthesis, reduction of glucose transporter-4 
(GLUT4) and insulin receptor substrate-1 expression, and 
suppression of insulin-induced lipogenesis [9]. Their find-
ings supported our study since 1 pg/ml increased in serum 
IL-6 level was associated with 0.031units increased in 
HOMA-IR index on observed value of present study. It in-
dicated that occurrence of insulin resistance was increased 
with high IL6 level. In present study, a significant weak 
positive correlation was found between HOMA-IR and se-
rum IL-6 level in this study population (r=0.237, p=0.009, 
n=120). This finding was similar to previous studies [6,7,27]. 
The present study showed that median (IQR) serum 
leptin level of obese subjects (6(5.6) pg/ml) was signifi-
cantly higher than that of non-obese subjects (3(2.48) pg/
ml) (p < 0.001). The findings of present study agree with 
the studies of Stelzer et al [3], Al Maskari and Alnaqdy [4] 
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and Osegbe et al [14]. Elevated serum leptin level in obe-
sity is due to positive correlation between serum leptin 
and BMI, and more fat mass and more leptin synthesis in 
adipocytes of obesity [28]. In addition, serum leptin level 
is significantly and weak positively correlated with HO-
MA-IR in study population of present study (r=0.306, p= 
0.001, n=120). This finding was similar to previous stud-
ies [12-14]. When adipocytes are exposed to glucose, insulin 
stimulates production of leptin to reduce food intake and 
increase energy expenditure whereas leptin decreases the 
secretion of insulin via a negative feedback and enhances 
tissue sensitivity to insulin (adipoinsular axis) [29]. In high 
serum leptin levels probably reflecting leptin resistance, 
deregulation of the adipocyte-insulin axis results in hy-
perinsulinemia associated with       diabetes [30]. In pres-
ent study, there was also a significant linear relationship 
between serum leptin level and HOMA-IR (B=0.229, 
p=0.018). Our study presented that serum leptin level is a 
significant predicting factor for insulin resistance.
Moreover, there was a significantly decreased in mean 
serum testosterone level of obese subjects when compared 
with non-obese subjects in present study (4.07±1.34 vs 
5.55±2.43 pg/ml, p<0.001). Consistent with our study, 
Zumoff et al [15], Khaw and Barrett-Connor [16] and Gaps-
tur et al [17] had reported that serum testosterone level is 
inversely correlated with body fat in men. Evidence from 
androgen receptor knockout mouse models demonstrates 
that deficiency of androgen action decreases lipolysis and 
is mainly responsible for the induction of obesity [31].  Ad-
ditionally evidence is also accumulating that the reduced 
level of serum testosterone is an independent risk factor 
for diabetes and metabolic syndrome in men [18]. Holman 
et al [32] demonstrated that castration in male rats leads 
to the rapid development of insulin resistance, which is 
corrected by physiological testosterone replacement. The 
present study also showed that serum testosterone was 
significantly and weak negatively correlated to the HO-
MA-IR (r = -0.209; P =0.02, n=120) and negative linear 
relationship with HOMA-IR (B = -0.519, p<0.05). These 
findings agreed with previous studies [18,33]. 
Moreover, leptin and IL-6 had been found to have 
negative interaction with testosterone in in-vivo and 
in-vitro studies [19,20,34]. Both leptin and IL6 inhibit the 
stimulatory action of gonadotrophins on the Leydig cells 
of the testis to decrease testosterone production [20,35]. 
Administration of testosterone to men also suppressed 
serum leptin level [36] and IL-6 level [37]. Besides, leptin 
have closely related with inflammatory cytokines such as 
IL-6. Some studies reported that leptin may up-regulate 
IL-6 production via the activation of different intracellular 
signalling pathways [21] and another studies also reported 
that human IL6 enhanced central leptin action in mice [38]. 
The present study established significant negative correla-
tion between testosterone level and IL-6 level (r= -0.34, 
p<0.001, n=120) and between testosterone level and 
leptin level (r=-0.408, p<0.001, n=120). Likewise, there 
was significant positive correlation between leptin and 
IL-6 levels in our study (r=0.391, p<0.001, n=120). These 
above-mentioned findings agreed with previous studies 
[3,34,39-41].  However, conclusions cannot be drawn about 
causality given the cross-sectional nature of the data.
5. Conclusion
Lower serum testosterone level, higher IL-6 level and 
leptin level are found in the obese group. Furthermore, 
HOMA-IR was weak negatively correlated with testoster-
one level and, also weak positively correlated with IL-6 
as well as leptin. Therefore, obese men are more likely to 
have low testosterone, high inflammatory markers leptin 
and IL-6 which were associated with decreased insulin 
sensitivity suggest the need for an early metabolic assess-
ment. This knowledge is fostering exploration of the mo-
lecular and genetic basis of the disease and new approach-
es to its treatment and prevention.
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